Pharmacogenomic-guided rational therapeutic drug monitoring: conceptual framework and application platforms for atypical antipsychotics.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015415:Biomarkers; D002986:Clinical Trials as Topic; D003024:Clozapine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D016503:Drug Delivery Systems; D004347:Drug Interactions; D016903:Drug Monitoring; D006801:Humans; D010597:Pharmacogenetics; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D015415:Biomarkers; D003577:Cytochrome P-450 Enzyme System; D003024:Clozapine